CHM
Click for more information
10.5% 2.1¢ chimeric therapeutics limited

Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-13

  1. dalts66
    4,330 Posts.
    lightbulb Created with Sketch. 2021
    clock Created with Sketch.
    22/07/24
    13:16
    Post #: 74856897
    its pretty exciting to sit and watch a novel drug hit an arm for the first time. Even more exciting when you own a percentage of that new drug.

    From the people who doodled an idea on a notepad many years ago, to the patient who hoping this new treatment works, to the share holder who sits back and watches as this all unfolds, its a pretty special occasion.
    CHM Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.002(10.5%) 		Mkt cap ! $19.27M
Open High Low Value Volume
1.9¢ 2.2¢ 1.9¢ $53.04K 2.550M

Buyers (Bids)

No. Vol. Price($)
2 198467 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 922473 1
View Market Depth
Last trade - 15.54pm 22/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.